Results 11 to 20 of about 1,444,460 (248)

Day-case total hip arthroplasty: a literature review and development of a hospital pathway

Bone & Joint Open, 2021
Aims: We present the development of a day-case total hip arthroplasty (THA) pathway in a UK National Health Service institution in conjunction with an extensive evidence-based summary of the interventions used to achieve successful day-case THA to which ...
Joshua W. Thompson, Warran Wignadasan, Mazin Ibrahim, Lucy Beasley, Sujith Konan, Ricci Plastow, Ahmed Magan, Fares S. Haddad   +7 more
doaj   +1 more source

Long-acting growth hormones: innovations in treatment and guidance on patient selection in pediatric growth hormone deficiency [PDF]

Annals of Pediatric Endocrinology & Metabolism
Long-acting growth hormones (LAGHs) represent a significant advancement in the treatment of pediatric GH deficiency, offering an alternative to daily recombinant human GH (rhGH) therapy.
Chiara Rodaro, Gianluca Tamaro, Elena Faleschini, Gianluca Tornese   +3 more
doaj   +1 more source

Prediction of Tissue Damage Using a User-Independent Machine Learning Algorithm vs. Tmax Threshold Maps

Clinical and Translational Neuroscience, 2021
(1) Background: To test the accuracy of a fully automated stroke tissue estimation algorithm (FASTER) to predict final lesion volumes in an independent dataset in patients with acute stroke; (2) Methods: Tissue-at-risk prediction was performed in 31 ...
Arsany Hakim, Benjamin Messerli, Raphael Meier, Tomas Dobrocky, Sebastian Bellwald, Simon Jung, Richard McKinley, Roland Wiest   +7 more
doaj   +1 more source

Selection of patients [PDF]

Journal of Medical Ethics, 1982
The author joins the discussion on selection of patients in the face of life-saving resources initiated in the Journal by Parsons and Lock, Mooney and the editorial in the December 1980 issue. In this article several selection systems are discussed. The author is in favour of a `criteria-system'. The criteria for such a system are elaborated.
openaire   +2 more sources

The current role of secondary cytoreductive surgery for recurrent ovarian cancer

Frontiers in Oncology, 2022
Ovarian cancer represents worldwide the second most frequent and the most fatal gynecological malignancy, with approximately two thirds of the patients presenting with advanced disease. Cytoreductive surgery, primary or after neoadjuvant chemotherapy, in
Eelco de Bree, Dimosthenis Michelakis, Elisavet Anagnostopoulou   +2 more
doaj   +1 more source

Association of radiation dose intensity with overall survival in patients with distant metastases

Cancer Medicine, 2021
Background Patients with metastatic cancer referred to radiation oncology have diverse prognoses and there is significant interest in personalizing treatment.
Johnny Kao, Mark K. Farrugia, Samantha Frontario, Amanda Zucker, Emily Copel, John Loscalzo, Ashish Sangal, Boramir Darakchiev, Anurag Singh, Symeon Missios   +9 more
doaj   +1 more source

Identifying multimorbid patients with high care needs - A study based on electronic medical record data

European Journal of General Practice, 2020
Background Patients with multimorbidity who frequently contact the general practice, use emergency care or have unplanned hospitalisations, may benefit from a proactive integrated care intervention. General practitioners are not always aware of who these
Marianne Heins, Joke Korevaar, Francois Schellevis, Mieke Rijken   +3 more
doaj   +1 more source

CD47‐SIRPα blocking‐based immunotherapy: Current and prospective therapeutic strategies

Clinical and Translational Medicine, 2022
Background The CD47‐signal regulatory protein alpha (SIRPα) ‘don't eat me’ signalling axis is perhaps the most prominent innate immune checkpoint to date.
Renée Bouwstra, Tom vanMeerten, Edwin Bremer   +2 more
doaj   +1 more source

Adverse outcomes in nontrial like patients on commercial HeartMate 3 LVAD support

JHLT Open, 2023
Background: Patient selection for real-world use of HeartMate 3 left ventricular assist device (HM3 LVAD) differs from that of clinical trials. We assessed adverse-event rates between “nontrial like” (NTL) and “trial like” (TL) patients who underwent ...
Laura Coyle, APN, Colleen Gallagher, BSN, Nicole Graney, APN, Lisa Kukla, APN, Robin Paliga, APN, Kylie Hughes, APN, Rachel Pedersen, BA, Kathleen Schultz, APN, Adam JT Schuldt, MD, PhD, Nasir Sulemanjee, MD, Gregory P. Macaluso, MD, Sunil Pauwaa, MD, James Monaco, MD, Mark Dela Cruz, MD, William G. Cotts, MD, Nikhil Narang, MD, Patroklos S. Pappas, MD, Antone J. Tatooles, MD, Vinh Q. Chau, MD   +18 more
doaj   +1 more source

Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort

Frontiers in Oncology, 2023
BackgroundThe role of stereotactic ablative radiation therapy (SABR) as local treatment option after chemotherapy for locally advanced pancreatic cancer (LAPC) is evolving.
D. Doppenberg, D. Doppenberg, D. Doppenberg, F. J. Lagerwaard, F. J. Lagerwaard, S. van Dieren, M. R. Meijerink, M. R. Meijerink, J. J. van der Vliet, J. J. van der Vliet, J. J. van der Vliet, M. G. Besselink, M. G. Besselink, G. van Tienhoven, G. van Tienhoven, E. Versteijne, E. Versteijne, B. J. Slotman, B. J. Slotman, J. W. Wilmink, J. W. Wilmink, G. Kazemier, G. Kazemier, A. M. E. Bruynzeel, A. M. E. Bruynzeel   +24 more
doaj   +1 more source